Skip to main content

05.08.2019 | Hepatitis B (JK Lim, Section Editor) | Ausgabe 3/2019 Open Access

Current Hepatology Reports 3/2019

Strategies for Global Elimination of Chronic HBV Infection: 2019 Update

Current Hepatology Reports > Ausgabe 3/2019
Shevanthi Nayagam, Mark Thursz
Wichtige Hinweise
This article is part of the Topical Collection on Hepatitis B

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Purpose of Review

With just over a decade to go before the WHO 2030 hepatitis elimination targets, this review takes a global perspective at the major challenges standing in the way of hepatitis B virus (HBV) elimination and discusses potential innovative solutions on the horizon for use in high burden settings.

Recent Findings

Universal HBV infant vaccination has been an incredible success. However, in order to reach the elimination targets, efforts now need to urgently focus on scaling up HBV prevention of mother-to-child (PMTCT) interventions, particularly in sub-Saharan Africa and increasing population level testing and treatment.


Innovative outreach strategies, simplified diagnostics and novel biomarkers and integration of systems are promising solutions to allow HBV elimination to be reached in an effective and affordable way. This should go alongside careful financing, policy planning and establishment of strong surveillance systems.

Unsere Produktempfehlungen

e.Med Interdisziplinär


Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf

e.Med Innere Medizin


Mit e.Med Innere Medizin erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Innere Medizin, den Premium-Inhalten der internistischen Fachzeitschriften, inklusive einer gedruckten internistischen Zeitschrift Ihrer Wahl.

e.Med Allgemeinmedizin


Mit e.Med Allgemeinmedizin erhalten Sie Zugang zu allen CME-Fortbildungen und Premium-Inhalten der allgemeinmedizinischen Zeitschriften, inklusive einer gedruckten Allgemeinmedizin-Zeitschrift Ihrer Wahl.

Über diesen Artikel

Weitere Artikel der Ausgabe 3/2019

Current Hepatology Reports 3/2019 Zur Ausgabe

Drug-Induced Liver Injury (P Hayashi, Section Editor)

The Role of Liver Biopsy in Drug-Induced Liver Injury

Drug-Induced Liver Injury (P Hayashi, Section Editor)

Drug-Induced Liver Injury Due to Nonsteroidal Anti-inflammatory Drugs

Drug-Induced Liver Injury (P Hayashi, Section Editor)

Regional and Racial Differences in Drug-Induced Liver Injury

Drug-Induced Liver Injury (P Hayashi, Section Editor)

Global Epidemiology of Drug-Induced Liver Injury (DILI)

Neu im Fachgebiet Innere Medizin

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Innere Medizin und bleiben Sie gut informiert – ganz bequem per eMail.

© Springer Medizin